Butcher Arthur C's Form 4/A amendment
AmendedBoston Scientific Corp (BSX) · filed Aug 2, 2021
- Accession no.
- 0001225208-21-011029
- Filed
- Aug 2, 2021
- Trade date
- Jul 27, 2021
- Filing delay
- 6 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jul 27, 2021
This filing lists 1 non-derivative transaction. It carries over 2 transactions from the original filing that it did not restate. Open-market sales total $435.3K. It was filed 6 days after the trade.
This amendment restates part of 0001225208-21-010897 (filed Jul 27, 2021). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Butcher Arthur CCIK 0001678249 | Officer (EVP&Pres, Asia Pacific) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2021 | Common Stock | SSaleDisposed | −9,673 | $45.00F2 | −$435,285 | 25,749 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001225208-21-010897 (filed Jul 27, 2021).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2021 | Common Stock | MOption exerciseAcquired | +4,250 | $13.08 | +$55,590 | 35,422 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2021 | Common Stock | MOption exerciseDisposed | −4,250 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2
Represents the weighted average sale price. These shares were sold in multiple transactions at $45.00 and $45.02. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. On July 27, 2021, the reporting person filed a Form 4 which inadvertently misreported the average sale price of the transactions. In fact, as reported in this amendment, the average sale price was $45.0002.
Referenced by the price of 1 transaction in Table I.